A Phase 1/2, Open-Label, Single-Arm and Randomized Parallel-Group Study to Investigate the Safety andEfficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) Compared withBelimumab in Subjects with Active Systemic Lupus Erythem

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences